Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

<p>Kaplan-Meier curves of overall survival of patients with long-term response (LTR), short-term response (STR), and progressive disease (PD) from individual sites.</p>

שמור ב:

מידע ביבליוגרפי
מחבר ראשי:	Rohit Thummalapalli (17314483) (author)
מחברים אחרים:	Biagio Ricciuti (14951247) (author), Chaitanya Bandlamudi (15047205) (author), Daniel Muldoon (17314486) (author), Hira Rizvi (16547594) (author), Arielle Elkrief (15055750) (author), Jia Luo (15034764) (author), Joao V. Alessi (17314489) (author), Federica Pecci (15561470) (author), Giuseppe Lamberti (15024714) (author), Alessandro Di Federico (15561473) (author), Lingzhi Hong (17314492) (author), Jianjun Zhang (16041833) (author), John V. Heymach (14934698) (author), Don L. Gibbons (15055721) (author), Andrew J. Plodkowski (15028415) (author), Vignesh Ravichandran (15052350) (author), Mark T.A. Donoghue (15054209) (author), Chad Vanderbilt (15050973) (author), Marc Ladanyi (15050661) (author), Charles M. Rudin (11572933) (author), Mark G. Kris (15055774) (author), Gregory J. Riely (14961725) (author), Jamie E. Chaft (14937195) (author), Matthew D. Hellmann (14937198) (author), Natalie I. Vokes (17314495) (author), Mark M. Awad (14961722) (author), Adam J. Schoenfeld (15022025) (author)
יצא לאור:	2025
נושאים:	Cancer Cancer Detection and Diagnosis Immuno-oncology Clinical Research and Trials Biomarkers Prognostic biomarkers Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Lung Cancer Precision Medicine
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים

Supplementary Figure S1 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S11 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S12 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S13 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S14 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S15 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S2 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S4 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S6 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S7 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S8 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Figure S9 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Table S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Table S4 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
מאת: Rohit Thummalapalli (17314483)
יצא לאור: (2025)

Supplementary Tables S1-S10 from <i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
מאת: Sunho Park (15053897)
יצא לאור: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
מאת: Hansol Lee (15054787)
יצא לאור: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
מאת: Hansol Lee (15054787)
יצא לאור: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
מאת: Hansol Lee (15054787)
יצא לאור: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
מאת: Hansol Lee (15054787)
יצא לאור: (2025)

Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
מאת: Joseph Toker (15399882)
יצא לאור: (2025)

Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
מאת: Joseph Toker (15399882)
יצא לאור: (2025)

Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
מאת: Joseph Toker (15399882)
יצא לאור: (2025)

Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
מאת: Joseph Toker (15399882)
יצא לאור: (2025)

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
מאת: Joseph Toker (15399882)
יצא לאור: (2025)

Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
מאת: Joseph Toker (15399882)
יצא לאור: (2025)

Table S8 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
מאת: Joseph Toker (15399882)
יצא לאור: (2025)

Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
מאת: Ankita Mitra (17141783)
יצא לאור: (2025)

Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
מאת: Ankita Mitra (17141783)
יצא לאור: (2025)

CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
מאת: Ankita Mitra (17141783)
יצא לאור: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
מאת: Aleksandar Obradovic (7549517)
יצא לאור: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
מאת: Aleksandar Obradovic (7549517)
יצא לאור: (2025)

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
מאת: Sonia A. Patel (15055688)
יצא לאור: (2025)

Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
מאת: Sonia A. Patel (15055688)
יצא לאור: (2025)

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
מאת: Sonia A. Patel (15055688)
יצא לאור: (2025)

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
מאת: Sonia A. Patel (15055688)
יצא לאור: (2025)

Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
מאת: Sonia A. Patel (15055688)
יצא לאור: (2025)

Supplementary Data 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
מאת: Nam Q. Bui (14958210)
יצא לאור: (2025)

Figure S1 from Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer
מאת: Samuel Rosner (15054884)
יצא לאור: (2025)

Cannot write session to /tmp/vufind_sessions/sess_118tik9mtuusn2242s95lcp6du